logo_new.jpg
Correction: ObsEva SA to present at the SVB LEERINK 9th Annual Global Healthcare Conference February 26th 2020
18 févr. 2020 03h48 HE | ObsEva SA
Geneva, Switzerland and Boston, MA – February 18, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s...
logo_new.jpg
ObsEva SA to present at the SVB LEERINK 9th Annual Global Healthcare Conference February 26th 2020
18 févr. 2020 01h00 HE | ObsEva SA
Geneva, Switzerland and Boston, MA – February 18, 2019 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Present at the 8th SVB Leerink Global Healthcare Conference
22 févr. 2019 07h00 HE | BeiGene, LTD.
CAMBRIDGE, Mass. and BEIJING, China, Feb. 22, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
logo_new.jpg
ObsEva SA to Participate in Upcoming Investor Conferences
22 févr. 2019 01h00 HE | ObsEva SA
Geneva, Switzerland and Boston, MA – February 22, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
red.jpg
RedHill Biopharma to Present at the 8th Annual SVB Leerink Healthcare Conference
19 févr. 2019 07h00 HE | RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 19, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty...
logo_ProQR-150x150.png
ProQR to Present at Upcoming Scientific Meeting and Investor Conference
06 févr. 2018 07h00 HE | ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
21 sept. 2017 08h25 HE | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
logo_ProQR-150x150.png
ProQR to Present at Two Investor Conferences in September
21 sept. 2017 07h00 HE | ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Sept. 21, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that the Company will present at two investor conferences during the month of...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference
09 févr. 2017 06h30 HE | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
EPIRUS Biopharmaceut
EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global Healthcare Conference
03 févr. 2016 09h00 HE | EPIRUS Biopharmaceuticals, Inc.
BOSTON, Feb. 03, 2016 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a biosimilar company focused on the global development and commercialization of biosimilar monoclonal...